Emerging-Arboviruses-Why-Today.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Flavivirus: from Structure to Therapeutics Development
life Review Flavivirus: From Structure to Therapeutics Development Rong Zhao 1,2,†, Meiyue Wang 1,2,†, Jing Cao 1,2, Jing Shen 1,2, Xin Zhou 3, Deping Wang 1,2,* and Jimin Cao 1,2,* 1 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China; [email protected] (R.Z.); [email protected] (M.W.); [email protected] (J.C.); [email protected] (J.S.) 2 Department of Physiology, Shanxi Medical University, Taiyuan 030001, China 3 Department of Medical Imaging, Shanxi Medical University, Taiyuan 030001, China; [email protected] * Correspondence: [email protected] (D.W.); [email protected] (J.C.) † These authors contributed equally to this work. Abstract: Flaviviruses are still a hidden threat to global human safety, as we are reminded by recent reports of dengue virus infections in Singapore and African-lineage-like Zika virus infections in Brazil. Therapeutic drugs or vaccines for flavivirus infections are in urgent need but are not well developed. The Flaviviridae family comprises a large group of enveloped viruses with a single-strand RNA genome of positive polarity. The genome of flavivirus encodes ten proteins, and each of them plays a different and important role in viral infection. In this review, we briefly summarized the major information of flavivirus and further introduced some strategies for the design and development of vaccines and anti-flavivirus compound drugs based on the structure of the viral proteins. There is no doubt that in the past few years, studies of antiviral drugs have achieved solid progress based on better understanding of the flavivirus biology. -
The Role of Genetic Diversity in the Replication, Pathogenicity and Virulence of Murray Valley Encephalitis Virus
School of Biomedical Sciences The Role of Genetic Diversity in the Replication, Pathogenicity and Virulence of Murray Valley Encephalitis Virus Aziz-ur-Rahman Niazi This thesis is presented for the Degree of Doctor of Philosophy of Curtin University September 2013 Declaration To the best of my knowledge and belief, this thesis contains no material previously published by any other person except where due acknowledgment has been made. This thesis contains no material which has been accepted for the award of any other degree or diploma in any university. Signature:…………………. Date:………………………. Acknowledgement First, I am humbly grateful to The Almighty God for granting me both the ability and determination to carry out this PhD. Next, I express my sincerest gratitude to both my parents who I hold with the highest regard, for their support and affability that made the undertaking of this thesis possible. I only wish that my mother were still alive to share in its completion. My sincere thanks are extended to my wife, Sonia Mohammadi, whom I am forever indebted to for giving up her ambitions of going to university to instead raise our lovely baby daughter, Alia Saba Niazi, born at the beginning of this PhD. Sonia is now expecting our son who will be born soon after completion of this PhD. Special heartfelt thanks also go to my extended family back home whose support has provided me with additional strength and energy to complete this PhD. I would like to cordially express my thanks to my supervisor, Dr David Thomas Williams, first for his help in applying for an Australian Biosecurity Cooperative Research Centre (AB-CRC) scholarship, then for guiding me and inspiring me to be a virologist. -
Data-Driven Identification of Potential Zika Virus Vectors Michelle V Evans1,2*, Tad a Dallas1,3, Barbara a Han4, Courtney C Murdock1,2,5,6,7,8, John M Drake1,2,8
RESEARCH ARTICLE Data-driven identification of potential Zika virus vectors Michelle V Evans1,2*, Tad A Dallas1,3, Barbara A Han4, Courtney C Murdock1,2,5,6,7,8, John M Drake1,2,8 1Odum School of Ecology, University of Georgia, Athens, United States; 2Center for the Ecology of Infectious Diseases, University of Georgia, Athens, United States; 3Department of Environmental Science and Policy, University of California-Davis, Davis, United States; 4Cary Institute of Ecosystem Studies, Millbrook, United States; 5Department of Infectious Disease, University of Georgia, Athens, United States; 6Center for Tropical Emerging Global Diseases, University of Georgia, Athens, United States; 7Center for Vaccines and Immunology, University of Georgia, Athens, United States; 8River Basin Center, University of Georgia, Athens, United States Abstract Zika is an emerging virus whose rapid spread is of great public health concern. Knowledge about transmission remains incomplete, especially concerning potential transmission in geographic areas in which it has not yet been introduced. To identify unknown vectors of Zika, we developed a data-driven model linking vector species and the Zika virus via vector-virus trait combinations that confer a propensity toward associations in an ecological network connecting flaviviruses and their mosquito vectors. Our model predicts that thirty-five species may be able to transmit the virus, seven of which are found in the continental United States, including Culex quinquefasciatus and Cx. pipiens. We suggest that empirical studies prioritize these species to confirm predictions of vector competence, enabling the correct identification of populations at risk for transmission within the United States. *For correspondence: mvevans@ DOI: 10.7554/eLife.22053.001 uga.edu Competing interests: The authors declare that no competing interests exist. -
Efficacy of Vaccines in Animal Models of Ebolavirus Disease
Supplemental Table 1. Efficacy of vaccines in animal models of Ebolavirus disease. Vaccines Immunization Schedule Mouse Model Guinea Pig Model NHP Model Virus Vectors HPIV3 Immunogens Guinea Pigs: Complete protection Complete protection HPIV3 ∆HN-F/ EBOV GP IN 4 x 106 PFU of HPIV3 with HPIV3 ∆HN-F/EBOV with 2 doses of [1] ∆HN-F/EBOV GP or GP, HPIV3/EBOV GP, or HPIV3/EBOV GP [3] EBOV GP [1-3] HPIV3/EBOV GP [1] HPIV3/EBOV NP [1, 2] No advantage to EBOV NP [2] IN 105.3 PFU of HPIV/EBOV Strong humoral response bivalent vaccines EBOV GP + NP [3] GP or NP [2] EBOV GP +GM-CSF [3] HPIV3- NHPs: 6 IN plus IT 4 x 10 TCID50 of HPIV3/EBOV GP, HPIV3/EBOV GP+GM-CSF, HPIV3/EBOVGP NP or 2 x 7 10 TCID50 of HPIV3/EBOV GP for 1–2 doses [3] RABV ∆GP/EBOV GP Mice: IM 5 x 105 FFU Complete protection with (Live attenuated) [4] either vector RABV/EBOV GP fused to EBOV GP incorporation into GCD of RABV virions not dependent on (inactivated) [4] RABV GCD Human Ad5 Immunogens Mice: With induced preexisting Ad5 With systemically CMVEBOV GP [5-9] IN, PO, IM 1 x 1010 [6] to 5 immunity, complete induced preexisting Ad5 CAGoptEBOV GP [8, 9] x 1010 [5] particles of protection with only IN immunity, complete Ad5/CMVEBOV GP Ad5/CMVEBOV GP [5] protection with IN IP 1 x 108 PFU With no Ad5 immunity: Ad5/CMVEBOV GP [8] Ad5/CMVEBOV GP[7] complete protection With mucosally induced IM 1 x 104–1 x 107 IFU of regardless of route [5-7, 9] preexisting Ad5 Ad5/CMVEBOV GP or 1 x Mucosal immunization Ad5- immunity, 83% 104–1 x 106 IFU of EBOV GP increased cellular -
Sindbis Virus Infection in Resident Birds, Migratory Birds, and Humans, Finland Satu Kurkela,*† Osmo Rätti,‡ Eili Huhtamo,* Nathalie Y
Sindbis Virus Infection in Resident Birds, Migratory Birds, and Humans, Finland Satu Kurkela,*† Osmo Rätti,‡ Eili Huhtamo,* Nathalie Y. Uzcátegui,* J. Pekka Nuorti,§ Juha Laakkonen,*¶ Tytti Manni,* Pekka Helle,# Antti Vaheri,*† and Olli Vapalahti*†** Sindbis virus (SINV), a mosquito-borne virus that (the Americas). SINV seropositivity in humans has been causes rash and arthritis, has been causing outbreaks in reported in various areas, and antibodies to SINV have also humans every seventh year in northern Europe. To gain a been found from various bird (3–5) and mammal (6,7) spe- better understanding of SINV epidemiology in Finland, we cies. The virus has been isolated from several mosquito searched for SINV antibodies in 621 resident grouse, whose species, frogs (8), reed warblers (9), bats (10), ticks (11), population declines have coincided with human SINV out- and humans (12–14). breaks, and in 836 migratory birds. We used hemagglutina- tion-inhibition and neutralization tests for the bird samples Despite the wide distribution of SINV, symptomatic and enzyme immunoassays and hemagglutination-inhibition infections in humans have been reported in only a few for the human samples. SINV antibodies were fi rst found in geographically restricted areas, such as northern Europe, 3 birds (red-backed shrike, robin, song thrush) during their and occasionally in South Africa (12), Australia (15–18), spring migration to northern Europe. Of the grouse, 27.4% and China (13). In the early 1980s in Finland, serologic were seropositive in 2003 (1 year after a human outbreak), evidence associated SINV with rash and arthritis, known but only 1.4% were seropositive in 2004. -
Potential Arbovirus Emergence and Implications for the United Kingdom Ernest Andrew Gould,* Stephen Higgs,† Alan Buckley,* and Tamara Sergeevna Gritsun*
Potential Arbovirus Emergence and Implications for the United Kingdom Ernest Andrew Gould,* Stephen Higgs,† Alan Buckley,* and Tamara Sergeevna Gritsun* Arboviruses have evolved a number of strategies to Chikungunya virus and in the family Bunyaviridae, sand- survive environmental challenges. This review examines fly fever Naples virus (often referred to as Toscana virus), the factors that may determine arbovirus emergence, pro- sandfly fever Sicilian virus, Crimean-Congo hemorrhagic vides examples of arboviruses that have emerged into new fever virus (CCHFV), Inkoo virus, and Tahyna virus, habitats, reviews the arbovirus situation in western Europe which is widespread throughout Europe. Rift Valley fever in detail, discusses potential arthropod vectors, and attempts to predict the risk for arbovirus emergence in the virus (RVFV) and Nairobi sheep disease virus (NSDV) United Kingdom. We conclude that climate change is prob- could be introduced to Europe from Africa through animal ably the most important requirement for the emergence of transportation. Finally, the family Reoviridae contains a arthropodborne diseases such as dengue fever, yellow variety of animal arbovirus pathogens, including blue- fever, Rift Valley fever, Japanese encephalitis, Crimean- tongue virus and African horse sickness virus, both known Congo hemorrhagic fever, bluetongue, and African horse to be circulating in Europe. This review considers whether sickness in the United Kingdom. While other arboviruses, any of these pathogenic arboviruses are likely to emerge such as West Nile virus, Sindbis virus, Tahyna virus, and and cause disease in the United Kingdom in the foresee- Louping ill virus, apparently circulate in the United able future. Kingdom, they do not appear to present an imminent threat to humans or animals. -
First Detection of the West Nile Virus Koutango Lineage in Sandflies In
pathogens Article First Detection of the West Nile Virus Koutango Lineage in Sandflies in Niger Gamou Fall 1,* , Diawo Diallo 2 , Hadiza Soumaila 3,4, El Hadji Ndiaye 2 , Adamou Lagare 5, Bacary Djilocalisse Sadio 1, Marie Henriette Dior Ndione 1, Michael Wiley 6,7 , Moussa Dia 1, Mamadou Diop 8, Arame Ba 1, Fati Sidikou 5, Bienvenu Baruani Ngoy 9, Oumar Faye 1, Jean Testa 5, Cheikh Loucoubar 8 , Amadou Alpha Sall 1, Mawlouth Diallo 2 and Ousmane Faye 1 1 Pole of Virology, WHO Collaborating Center For Arbovirus and Haemorrhagic Fever Virus, Institut Pasteur, Dakar BP 220, Senegal; [email protected] (B.D.S.); [email protected] (M.H.D.N.); [email protected] (M.D.); [email protected] (A.B.); [email protected] (O.F.); [email protected] (A.A.S.); [email protected] (O.F.) 2 Citation: Fall, G.; Diallo, D.; Pole of Zoology, Medical Entomology Unit, Institut Pasteur, Dakar BP 220, Senegal; Soumaila, H.; Ndiaye, E.H.; Lagare, [email protected] (D.D.); [email protected] (E.H.N.); [email protected] (M.D.) 3 A.; Sadio, B.D.; Ndione, M.H.D.; Programme National de Lutte contre le Paludisme, Ministère de la Santé Publique du Niger, Niamey BP 623, Niger; [email protected] Wiley, M.; Dia, M.; Diop, M.; et al. 4 PMI Vector Link Project, Niamey BP 11051, Niger First Detection of the West Nile Virus 5 Centre de Recherche Médicale et Sanitaire, Niamey BP 10887, Niger; [email protected] (A.L.); Koutango Lineage in Sandflies in [email protected] (F.S.); [email protected] (J.T.) Niger. -
Competition Between Usutu Virus and West Nile Virus During Simultaneous and Sequential Infection of Culex Pipiens Mosquitoes
Emerging Microbes & Infections ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/temi20 Competition between Usutu virus and West Nile virus during simultaneous and sequential infection of Culex pipiens mosquitoes Haidong Wang , Sandra R. Abbo , Tessa M. Visser , Marcel Westenberg , Corinne Geertsema , Jelke J. Fros , Constantianus J. M. Koenraadt & Gorben P. Pijlman To cite this article: Haidong Wang , Sandra R. Abbo , Tessa M. Visser , Marcel Westenberg , Corinne Geertsema , Jelke J. Fros , Constantianus J. M. Koenraadt & Gorben P. Pijlman (2020) Competition between Usutu virus and West Nile virus during simultaneous and sequential infection of Culexpipiens mosquitoes, Emerging Microbes & Infections, 9:1, 2642-2652, DOI: 10.1080/22221751.2020.1854623 To link to this article: https://doi.org/10.1080/22221751.2020.1854623 © 2020 The Author(s). Published by Informa View supplementary material UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd Published online: 14 Dec 2020. Submit your article to this journal Article views: 356 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=temi20 Emerging Microbes & Infections 2020, VOL. 9 https://doi.org/10.1080/22221751.2020.1854623 ORIGINAL ARTICLE Competition between Usutu virus and West Nile virus during simultaneous and sequential infection of Culex pipiens mosquitoes Haidong Wanga, Sandra R. Abboa, -
Usutu Virus: an Emerging Flavivirus in Europe
Viruses 2015, 7, 219-238; doi:10.3390/v7010219 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Usutu Virus: An Emerging Flavivirus in Europe 1,2,3 1,2,3 1,2,3 1,2,3 1,2,3 Usama Ashraf , Jing Ye , Xindi Ruan , Shengfeng Wan , Bibo Zhu and Shengbo Cao 1,2,3,* 1 State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, Hubei 430070, China; E-Mails: [email protected] (U.A.); [email protected] (J.Y.); [email protected] (X.R.); [email protected] (S.W.); [email protected] (B.Z.) 2 Laboratory of Animal Virology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei 430070, China 3 Laboratory of development of Veterinary Diagnostic Products, Ministry of Agriculture, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei 430070, China * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel./Fax: +86-278-728-2608. Academic Editor: Karyn Johnson Received: 11 November 2014 / Accepted: 13 January 2015 / Published: 19 January 2015 Abstract: Usutu virus (USUV) is an African mosquito-borne flavivirus belonging to the Japanese encephalitis virus serocomplex. USUV is closely related to Murray Valley encephalitis virus, Japanese encephalitis virus, and West Nile virus. USUV was discovered in South Africa in 1959. In Europe, the first true demonstration of circulation of USUV was reported in Austria in 2001 with a significant die-off of Eurasian blackbirds. In the subsequent years, USUV expanded to neighboring countries, including Italy, Germany, Spain, Hungary, Switzerland, Poland, England, Czech Republic, Greece, and Belgium, where it caused unusual mortality in birds. -
RNA Viruses As Tools in Gene Therapy and Vaccine Development
G C A T T A C G G C A T genes Review RNA Viruses as Tools in Gene Therapy and Vaccine Development Kenneth Lundstrom PanTherapeutics, Rte de Lavaux 49, CH1095 Lutry, Switzerland; [email protected]; Tel.: +41-79-776-6351 Received: 31 January 2019; Accepted: 21 February 2019; Published: 1 March 2019 Abstract: RNA viruses have been subjected to substantial engineering efforts to support gene therapy applications and vaccine development. Typically, retroviruses, lentiviruses, alphaviruses, flaviviruses rhabdoviruses, measles viruses, Newcastle disease viruses, and picornaviruses have been employed as expression vectors for treatment of various diseases including different types of cancers, hemophilia, and infectious diseases. Moreover, vaccination with viral vectors has evaluated immunogenicity against infectious agents and protection against challenges with pathogenic organisms. Several preclinical studies in animal models have confirmed both immune responses and protection against lethal challenges. Similarly, administration of RNA viral vectors in animals implanted with tumor xenografts resulted in tumor regression and prolonged survival, and in some cases complete tumor clearance. Based on preclinical results, clinical trials have been conducted to establish the safety of RNA virus delivery. Moreover, stem cell-based lentiviral therapy provided life-long production of factor VIII potentially generating a cure for hemophilia A. Several clinical trials on cancer patients have generated anti-tumor activity, prolonged survival, and -
Guiding Dengue Vaccine Development Using Knowledge Gained from the Success of the Yellow Fever Vaccine
Cellular & Molecular Immunology (2016) 13, 36–46 ß 2015 CSI and USTC. All rights reserved 1672-7681/15 $32.00 www.nature.com/cmi REVIEW Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine Huabin Liang, Min Lee and Xia Jin Flaviviruses comprise approximately 70 closely related RNA viruses. These include several mosquito-borne pathogens, such as yellow fever virus (YFV), dengue virus (DENV), and Japanese encephalitis virus (JEV), which can cause significant human diseases and thus are of great medical importance. Vaccines against both YFV and JEV have been used successfully in humans for decades; however, the development of a DENV vaccine has encountered considerable obstacles. Here, we review the protective immune responses elicited by the vaccine against YFV to provide some insights into the development of a protective DENV vaccine. Cellular & Molecular Immunology (2016) 13, 36–46; doi:10.1038/cmi.2015.76 Keywords: dengue virus; protective immunity; vaccine; yellow fever INTRODUCTION from a viremic patient and is capable of delivering viruses to its Flaviviruses belong to the family Flaviviridae, which includes offspring, thereby amplifying the number of carriers of infec- mosquito-borne pathogens such as yellow fever virus (YFV), tion.6,7 Because international travel has become more frequent, Japanese encephalitis virus (JEV), dengue virus (DENV), and infected vectors can be transported much more easily from an West Nile virus (WNV). Flaviviruses can cause human diseases endemic region to other areas of the world, rendering vector- and thus are considered medically important. According to borne diseases such as dengue fever a global health problem. -
The Molecular Characterization and the Generation of a Reverse Genetics System for Kyasanur Forest Disease Virus by Bradley
The Molecular Characterization and the Generation of a Reverse Genetics System for Kyasanur Forest Disease Virus by Bradley William Michael Cook A Thesis submitted to the Faculty of Graduate Studies of The University of Manitoba in partial fulfilment of the requirements of the degree of Master of Science Department of Microbiology University of Manitoba Winnipeg, Manitoba, Canada Copyright © 2010 by Bradley William Michael Cook 1 List of Abbreviations: AHFV - Alkhurma Hemorrhagic Fever Virus Amp – ampicillin APOIV - Apoi Virus ATP – adenosine tri-phosphate BAC – bacterial artificial chromosome BHK – Baby Hamster Kidney BSA – bovine serum albumin C1 – C-terminus fragment 1 C2 – C-terminus fragment 2 C - Capsid protein cDNA – comlementary Deoxyribonucleic acid CL – Containment Level CO2 – carbon dioxide cHP - capsid hairpin CNS - Central Nervous System CPE – cytopathic effect CS - complementary sequences DENV1-4 - Dengue Virus DIC - Disseminated Intravascular Coagulation (DIC) DNA – Deoxyribonucleic acid DTV - Deer Tick Virus 2 E - Envelope protein EDTA - ethylenediaminetetraacetic acid EM - Electron Microscopy EMCV – Encephalomyocarditis Virus ER - endoplasmic reticulum FBS – fetal bovine serum FP - fusion peptide GGEV - Greek Goat Encephalitis Virus GGYV - Gadgets Gully Virus GMP - Guanosine mono-phosphate GTP - Guanosine tri-phosphate HBV- Hepatitis B Virus HDV – Hepatitis Delta Virus HIV - Human Immunodeficiency Virus IFN – interferon IRES – internal ribosome entry sequence JEV - Japanese Encephalitis Virus KADV - Kadam Virus kDa -